Medtronic plc (MDT)

↓ Download CSV

CIK 0001613103 · NYSE · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Fiscal year ends Apr 24

In fiscal 2025, Medtronic plc reported revenue of $33.54B, up 3.6% from the prior year. The company was profitable, with a net margin of 13.9%. It held $91.68B in total assets against $43.42B in total liabilities.

Key ratios (FY2025)

17.8%
Operating margin
13.9%
Net margin
9.7%
Return on equity
+3.6%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$33.54B$32.36B$31.23B$31.69B$30.12B$28.91B$30.56B$29.95B$29.71B
Cost of Revenue$11.63B$11.22B$10.72B$10.14B$10.48B$9.42B$9.15B$9.07B$9.29B$9.14B
Gross Profit$20.90B$20.42B$19.69B
Operating Income$5.96B$5.14B$5.49B$5.75B$4.48B$4.79B$6.27B$6.64B$5.38B$5.36B
Net Income$4.66B$3.68B$3.76B$5.04B$3.61B$4.79B$4.63B$3.10B$4.03B$3.54B
EPS (Diluted)$3.61$2.76$2.82$3.73$2.66$3.54$3.41$2.27$2.89$2.48
Total Assets$91.68B$89.98B$90.95B$90.98B$93.08B$90.69B$89.69B$91.39B$99.86B$99.64B
Total Liabilities$43.42B$39.56B$39.28B$38.26B$41.48B$39.82B$39.48B$40.57B$49.53B$47.58B
Shareholders' Equity$48.02B$50.21B$51.48B$52.55B$51.43B$50.74B$50.09B$50.72B$50.21B$52.06B
Cash & Equivalents$2.22B$1.28B$1.54B$3.71B$3.59B$4.14B$4.39B$3.67B$4.97B$2.88B
Operating Cash Flow$7.04B$6.79B$6.04B$7.35B$6.24B$7.23B$7.01B$4.68B$6.88B$5.22B
Capital Expenditures$1.86B$1.59B$1.46B$1.37B$1.35B$1.21B$1.13B$1.07B$1.25B$1.05B
Shares Outstanding1.29B1.33B1.33B1.35B1.35B1.35B1.36B1.37B1.39B1.43B
Dividends Per Share$2.80$2.76$2.72$2.52$2.32$2.16$2.00$1.84$1.72$1.52